Seattle, WA -- (SBWIRE) -- 11/29/2019 -- Stroke is a medical condition caused due to a poor flow of blood to the brain. They are classified into ischemic and hemorrhagic, ischemic occur due to lack of supply of blood and hemorrhagic occur due to bleeding, in both cases brain does not work properly. Inability to move or feel on one side of the body, problems in speaking or understanding, dizziness, or loss of vision to one side are some of the symptoms of a stroke. It is one of the major causes of death and mostly occurs in the old age population. However, with the advancement in medical science, there are various treatments available to prevent deaths from strokes.

Rising cases of hypertension, atrial fibrillation, and coronary heart diseases leading to the increasing rate of stroke, which is expected to fuel the market growth of stroke diagnostics and therapeutics. According to the World Health Organization, 15 million people suffer strokes worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Moreover, high blood pressure contributes to more than 12.7 million strokes worldwide.

Fill the form to gain deeper on this market: https://www.stratagemmarketinsights.com/sample/6278

From the geographical perspective, North America is expected to gain significant growth over the forecast period and this can be attributed to the rising number of stroke-related death cases in the region. According to the WHO, stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. Moreover, rising spending by the U.S government in the healthcare sector for improving the facilities and reducing the fatalities rate is further expected to boost the regional market growth. According to the report published by Research America, Investment in medical and health research and development (R&D) in the U.S. grew by 13.3% from 2013 to 2015. The industry invested more than any other sector, representing 64.7% of total spending in 2015, followed by the federal government at 22.6%.

Key Developments:

-- In July 2019, MedCity and Stroke Association have entered into a collaboration to identify and support the development of digital health therapeutics and medical devices for patients living with the long-term health impact of stroke.

-- In May 2017, Brainomix and Boehringer Ingelheim collaborated for developing new technology that could dramatically shorten the diagnosis time of stroke patients. Brainomix team developed the rapid digital analysis of scans of patients admitted to the hospital with a stroke. The e-ASPECTS software acts as a standardized and rapid second-opinion tool that assists physicians on-site to choose an appropriate treatment based on the magnitude and nature of the brain damage.

-- In December 2016, researchers in Europe develop a new hybrid device that combines different imaging technologies and help stroke patients in particular to receive quicker diagnosis and treatment. The project "Predictive Prevention and Personalized Interventional Stroke Therapy - P3 Stroke" is being undertaken by the University of Erlangen-Nuremberg (FAU), in collaboration with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Abbott Laboratories
Cordis Corporation
Boston Scientific Corporation
Siemens AG
Genentech
Koninklijke Philips N.V
Medtronic plc
GE Healthcare
Stryker Corporation
Merck & Co.,Inc

By types, the market can be split into
Diagnostics
Therapeutics

By Application, the market can be split into
Ischemic Stroke
Haemorrhagic Stroke
Other

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

For More Information or Query or Customization Before Buying, Download Sample Report with Top 10 Market Leading Companies: https://www.stratagemmarketinsights.com/quiry/6278

Key questions answered in the report:

-- How does the demand for Stroke Diagnostics And Therapeutics in developing regions differ from developed countries?

-- How is the competition between the major global and prominent local players in this market?

-- Which are the high growth market segments in terms of product types, end users, regions, and countries?

About Stratagem Market Insights
Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.